Tevogen Bio Holdings Inc. (TVGN)
Automate Your Wheel Strategy on TVGN
With Tiblio's Option Bot, you can configure your own wheel strategy including TVGN - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowNews
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nation's Health and Prosperity
Published: February 14, 2025 by: GlobeNewsWire
Sentiment: Neutral
CEO of Tevogen Bio, Dr. Saadi addresses short selling and its potential impact on the nation's health and prosperity. Reaffirms commitment to shareholders.
Read More
Tevogen Bio CEO Congratulates RFK Jr. on His Confirmation as Secretary of the HHS; Echoes Commitment to Innovation and Affordability for Americans
Published: February 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
WARREN, N.J., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH, Founder and CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech company, congratulates Robert F. Kennedy Jr.'s as he begins his role at the head of Health and Human Services.
Read More
Tevogen Bio's Business Model Addresses Biopharma Industry Challenges with Cost-Efficient Innovation
Published: February 10, 2025 by: GlobeNewsWire
Sentiment: Neutral
WARREN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), is a clinical-stage specialty immunotherapy biotech company. As the biopharma industry faces increasing competition from international markets and an evolving regulatory landscape, Tevogen Bio's innovative business model positions it as a potential leader in the shift towards cost-efficient, value-driven healthcare.
Read More
About Tevogen Bio Holdings Inc. (TVGN)
- IPO Date 2022-01-05
- Website https://tevogen.com
- Industry Biotechnology
- CEO Ryan H. Saadi
- Employees 18